| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |